Molecular Designs Launches Urogenital Microbiota Panel to Detect Pathogens and Antibiotic Resistance

Urogenital Microbiota with ABX 53 Simplicity Panel™ delivers same-day research use only results, identifying 28 organisms and 25 resistance markers in a streamlined, lab-ready format

BIRMINGHAM, Ala., Sept. 3, 2025 /PRNewswire/ -- Molecular Designs, a developer and manufacturer of molecular infectious disease assays, today unveiled its Urogenital Microbiota with ABX 53 Simplicity Panel™, a next-generation multiplex PCR-based research use only panel designed to detect a wide range of urinary targets and antibiotic resistance (ABX) genes.

The new panel provides comprehensive detection of 28 urinary targets – 20 bacterial, 7 fungal, and 1 protozoan – along with 25 key ABX markers. By combining speed, accuracy, and ease of use, the panel helps labs deliver same-day results with a simplified workflow that reduces errors, saves time, and supports scalable testing environments.

"With drug resistance on the rise, labs are being asked to do more with fewer resources," said Michael Clark, CEO of Molecular Designs. "This panel was built to help them keep pace by providing comprehensive answers with a workflow that fits seamlessly into today's research lab environment."

Built for speed and simplicity, the Urogenital Microbiota with ABX 53 Simplicity Panel™ eliminates the delays associated with running multiple assays. Its ready-to-use 96 and 384-well format with breakaway panels (96-well only) that minimize waste, and a streamlined workflow reduces pipetting errors. The result is a consistent, lab-friendly solution that supports both daily operations and broader antimicrobial stewardship efforts.

"Antimicrobial resistance isn't just a lab challenge, it's one of the most pressing threats in medicine today," said Dr. Greer Massey, Chief Scientific Officer at Molecular Designs. "By combining urogenital target detection with resistance gene profiling in a single panel, this product gives researchers the insight they need to track emerging threats and make more informed decisions, faster."

Because of its design, the panel is well-suited for research labs seeking to track resistance mechanisms and microbial profiles across diverse urogenital samples. It equips laboratories with a timely tool to stay ahead as resistance rates continue to climb worldwide.

For more information on the Urogenital Microbiota with ABX 53 Simplicity Panel™, visit www.moleculardesigns.com.

All products are for research use only and not for use in diagnostic procedures.

About Molecular Designs
Molecular Designs was founded by physicians looking to simplify delivery of and increase accessibility to cost-effective, streamlined, and easy-to-use molecular technologies. It offers numerous multiplex PCR-based panels produced under GMP and ISO 13485:2016 quality standards for research use, as well as complementary reagents and instrumentation. For more information, please visit moleculardesigns.com and follow on LinkedIn.

Media Contact:
Yancey Casey
Amendola Communications on behalf of Molecular Designs
(678) 895-9401
[email protected]

SOURCE Molecular Designs